STOCK TITAN

AstroNova (ALOT) 10-Q Filings

ALOT

Here are the 10-Q quarterly reports from AstroNova, Inc. (ALOT) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow ALOT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALOT filings page.

Rhea-AI Summary

AstroNova reported first-quarter revenue of $39.4 million, up 4.4% from $37.7 million a year earlier, driven mainly by stronger Aerospace hardware sales. Gross profit rose to $14.4 million, with margin improving to 36.6% from 31.7% on better mix and lower manufacturing costs.

The company posted net income of $0.7 million, or $0.08 per diluted share, versus a prior-year loss of $0.4 million. Results included restructuring charges, non-recurring legal and professional fees, an inventory reserve reversal, and discretionary bonuses that together had a meaningful impact on quarterly earnings.

Product ID revenue was broadly flat at $26.1 million, as growth in professional label and mail/sheet printers was offset by weaker direct-to-package and desktop label printers. Aerospace revenue increased to $13.3 million, supported by commercial aircraft and regional/business jet demand. Management continues executing a restructuring program and reviewing strategic alternatives while managing leverage of about $20.6 million in total debt against $139.9 million in assets.

Rhea-AI Summary

AstroNova, Inc. (ALOT) reported interim filing details showing financing, segment and expense updates for the periods ended July 31, 2025 and August 3, 2024. The Product ID segment derives approximately 80% of its revenue from recurring supplies, parts and service. Fair-value estimates for acquired intangibles used a 0.75% relief-from-royalty rate and a 15.5% discount rate for trademark valuation. Credit agreements were amended to temporarily increase the revolving facility to $30.0 million until January 31, 2025, and the company borrowed EUR 14.0 million on a Term A-2 loan plus amounts under the revolving facility to fund a purchase. The Term A-2 loan requires quarterly principal payments through April 30, 2027 and a full payment on August 4, 2027. Interest rates on facilities vary by leverage, with EURIBOR-based margins of 1.60%–2.85%; other borrowing includes an equipment loan at 7.06% (monthly payments of $16,296 through Jan 23, 2029) and an MTEX term loan at 6.022% with monthly payments of EUR 17,402 ($18,795) through Dec 21, 2033. The company expects $3.0 million of annualized savings from restructuring actions. For six months, selling and marketing expense declined to $11.3 million (down 8.9%), G&A rose to $10.0 million (up 18.0%) including nonrecurring charges, and R&D was $3.1 million (4.2% of revenue). Equity plan and director compensation amendments and outstanding share counts are described; employees delivered 2,739 shares to cover taxes on vesting at an average market value of $9.01 per share.